scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005186908 |
P356 | DOI | 10.1186/SCRT540 |
P932 | PMC publication ID | 4417240 |
P698 | PubMed publication ID | 25582222 |
P5875 | ResearchGate publication ID | 272023167 |
P50 | author | Santiago G Miriuka | Q37838835 |
Gustavo Sevlever | Q57014307 | ||
Marcela Nilda García | Q109265509 | ||
P2093 | author name string | Leonardo Romorini | |
Alejandra Guberman | |||
Claudia Solari | |||
María Questa | |||
Gabriel Neiman | |||
María Elida Scassa | |||
Carlos Luzzani | |||
Ximena Garate | |||
Ana Lía Errecalde | |||
Darío Fernandez Espinosa | |||
P2860 | cites work | Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells | Q21245484 |
Derivation of multipotent mesenchymal precursors from human embryonic stem cells | Q24813785 | ||
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester | Q28248444 | ||
Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells | Q28729211 | ||
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue | Q29620725 | ||
Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties | Q33861809 | ||
Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. | Q33862395 | ||
Feeder-free growth of undifferentiated human embryonic stem cells | Q34093315 | ||
One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating | Q34211784 | ||
Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology | Q34234499 | ||
Functional and differential proteomic analyses to identify platelet derived factors affecting ex vivo expansion of mesenchymal stromal cells | Q34507997 | ||
Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. | Q34611461 | ||
Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. | Q34938156 | ||
Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro | Q35155712 | ||
Human embryonic stem cell-derived mesenchymal stromal cells | Q35681446 | ||
Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells | Q36563069 | ||
In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells | Q37081650 | ||
Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. | Q37200221 | ||
Long-term in vitro expansion alters the biology of adult mesenchymal stem cells | Q37269767 | ||
Good manufacturing practices production of mesenchymal stem/stromal cells. | Q37804393 | ||
Human embryonic stem cell-derived mesenchymal progenitors: an overview | Q37806175 | ||
Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures | Q38165928 | ||
Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells | Q38491284 | ||
Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media. | Q39435150 | ||
Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. | Q39512034 | ||
Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential. | Q39651691 | ||
Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. | Q39913781 | ||
Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes | Q39920526 | ||
Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract | Q40168400 | ||
An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. | Q40450006 | ||
Long-term culture of human embryonic stem cells in feeder-free conditions | Q40595172 | ||
Induced pluripotent stem cell generation using a single lentiviral stem cell cassette | Q40721564 | ||
Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis | Q41900937 | ||
Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells | Q42625062 | ||
The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation | Q43193050 | ||
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. | Q43222889 | ||
Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications | Q43898390 | ||
Generation of a pool of human platelet lysate and efficient use in cell culture. | Q45992553 | ||
The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy | Q47923503 | ||
Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. | Q50942078 | ||
Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. | Q51216266 | ||
Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. | Q54462820 | ||
Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs | Q56915439 | ||
Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population | Q59713756 | ||
Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate | Q84878975 | ||
P921 | main subject | mesenchymal stem cell | Q1922379 |
P304 | page(s) | 6 | |
P577 | publication date | 2015-01-12 | |
P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
P1476 | title | A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement | |
P478 | volume | 6 |
Q37352691 | AKT/GSK3β signaling pathway is critically involved in human pluripotent stem cell survival. |
Q40328895 | Characterization of Tunneling Nanotubes in Wharton's jelly Mesenchymal Stem Cells. An Intercellular Exchange of Components between Neighboring Cells |
Q64069386 | Comparison of human isogeneic Wharton's jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation |
Q58702140 | Current Strategies to Generate Human Mesenchymal Stem Cells In Vitro |
Q37432824 | Cyclin Kinase-independent role of p21CDKN1A in the promotion of nascent DNA elongation in unstressed cells. |
Q57158902 | Extracellular vesicles from pluripotent stem cell-derived mesenchymal stem cells acquire a stromal modulatory proteomic pattern during differentiation |
Q64080348 | Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA |
Q35974864 | Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199 |
Q54966071 | Identification of the miRNAome of early mesoderm progenitor cells and cardiomyocytes derived from human pluripotent stem cells. |
Q91703857 | Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells |
Q26770191 | Mesenchymal stem cells and immunomodulation: current status and future prospects |
Q48301241 | Optimized human platelet lysate as novel basis for a serum-, xeno-, and additive-free corneal endothelial cell and tissue culture. |
Q38999248 | Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells |
Q64249676 | Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming |
Q26747501 | Strategies to Optimize Adult Stem Cell Therapy for Tissue Regeneration |
Q26765255 | Use of platelet lysate for bone regeneration - are we ready for clinical translation? |
Search more.